The Brussels-based Innovative Medicines Initiative is launching three new projects around Alzheimer’s disease that will review current nomenclature, create a new network of patient data and test novel treatments in patients with early-stage disease. ---Subscribe to MedNous to access this article--- Regulation & Policy Research & University News
